Roivant Sciences Ltd. (ROIV)
26.46
-0.30
(-1.10%)
USD |
NASDAQ |
Feb 13, 16:00
26.46
0.00 (0.00%)
After-Hours: 16:44
Roivant Sciences Shareholders Equity (Quarterly) : 4.269B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Immunovant, Inc. | 986.14M |
| GSK Plc | 22.03B |
| Kiniksa Pharmaceuticals International Plc | 535.38M |
| Silence Therapeutics Plc | 74.06M |
| Adaptimmune Therapeutics Plc | -70.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.225B |
| Total Liabilities (Quarterly) | 251.14M |
| Debt to Equity Ratio | 0.0255 |
| Current Ratio | 30.66 |
| Net Debt Paydown Yield | -0.07% |